The main purpose of this legislation is to provide financial relief to individuals participating in clinical trials by excluding certain payments from their taxable income. This aims to encourage participation in clinical research, which is vital for developing new treatments and therapies. Key provisions of the legislation include the establishment of a new category in the tax code called "qualified clinical trial payments." These payments can include compensation for participation in an approved clinical trial or reimbursement for reasonable expenses related to that participation.